Medindia » Consumer Health » Health Information » Pagets disease of the breast - Prognosis

Pagets disease of the breast

Paget's disease of the breast - Prognosis

RSS Feeds   Text 
The disease prognosis depends on the underlying breast cancer.

The prognosis is poor when the patients have palpable breast mass. About 62% of Paget's disease patient have palpable breast mass and their survival rate is 40% after 5 years and 30 % after 10 years.

The survival rate of patients without palpable breast mass is 9% after 5 years and 80% after 10 years.

Conservatory breast surgery usually results in higher rates of recurrence of Paget's disease when compared to mastectomy.


Share it!
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
Posted by:  guest  Posted on: 03/18/2008
Error in this statement?- is 9% survival after 5 yrs supposed to say 90% "The survival rate of patients without palpable breast mass is 9% after 5 years and 80% after 10 years"




X
Related Links
Breast Self Examination
Women and Cancer
Breast Cancer
Citing this Health Article
The information on Medindia is factual, unbiased and authentic. If you find the content useful - PLEASE INCLUDE A LINK TO THIS PAGE.

Highlight the text, right-click, and select “copy”. Paste the link into your website, email, or any other HTML document.

News on Pagets disease of the breast
* Botanical Formula Slows Breast Cancer Metastasis
* Cardio-Pulmonary Function can be a Strong Indicator for Survival Chances of Breast Cancer Patients
* Post Surgery Will the Tumour Return? New Breast Cancer Test to Predict Exactly
* Heat Shock Protein Inhibitor And Hormonal Therapy Combo Tested in Breast Cancer Clinical Trial
* HDAC Inhibitor Successfully Targets and Destroys Triple Negative Breast Cancer
Total News Item 1474
Are you a member of Facebook? Become a fan of Medindia and get breaking news delivered to your Facebook page.